Cargando…
Drug development process and COVID-19 pandemic: Flourishing era of outsourcing
Traditional drug development is a tedious process with involvement of enormous cost and a high attrition rate. Outsourcing drug development services to contract research organizations (CROs) has become an important strategy for cost and risk reduction, capacity building, and data generation. The the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846916/ https://www.ncbi.nlm.nih.gov/pubmed/36537406 http://dx.doi.org/10.4103/ijp.ijp_318_22 |